Tornos, who joined Zimmer Biomet in November 2018 as Group President, Orthopedics, became Group President, Global Businesses and the Americas just one year later. Bard, Mr. Tornos served as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. Andrews Medicine Clinic and Celltex Therapeutics have formed a new company named Andrews Celltex Biologics. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology/Medical and Critical Care Division of Becton, Dickinson and Company. Together with healthcare professionals, we help millions of people live better lives. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomets expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Ivan is a great addition to our leadership team, bringing deep medical technology expertise and a strong history of successfully managing complex businesses across several continents, said Bryan Hanson, President and CEO of Zimmer Biomet. "As we continue to transform the Company, having Ivan at the helm in this newly-created and expanded role to drive forward, align and execute on our operations helps ensure we continue to deliver for our customers, patients and shareholders. Ivan Tornos: Chief Operating Officer: Of this total $785,000 was received as a salary, $808,356 was received as a bonus, $1,600,020 was received in stock options, $1,600,089 was awarded as stock and $85,444 came from other types of compensation. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. This cautionary statement is applicable to all forward-looking statements contained in this release. ; Tornos joined Zimmer Biomet in November 2018 as Group President . All Rights Reserved. Ivan Tornos Chief Operating Officer Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. Ivan Tornos 4mo Report this post One more day at the Smart Solutions, dream-building factory! Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Gl obal Urology, Medical and Critical Care Division of Becton, Dickinson and Company. In terms of my first steps in this expanded role, I am diving in to facilitate integration across our business. Further, the musculoskeletal healthcare provider said, Didier Deltort, who has served as the President of EMEA since August 2018, will be departing Zimmer Biomet for another professional appointment. This information is derived from proxy statements filed for the 2020 fiscal year. Mr. Tornos owns over 3,538 units of Zimmer Biomet Inc stockworth over 1,679,896$ and over the last 3 years he sold ZBH stock worth over 0$. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. For more information, visitwww.zimmerbiomet.comor follow Zimmer Biomet on Twitter atwww.twitter.com/zimmerbiomet. . to joining Zimmer Biomet, Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. He will lead all global business, global operations, clinical and medical education, global research and development, and new product development. Bard, most recently serving as President, Europe, Middle East and Africa Regions. Zimmer Biomet. Joining me today are Bryan Hanson, our Chairman, President, and CEO; EVP and CFO, Suki Upadhyay; and COO, Ivan Tornos. Plus500. Prior to that, he was with C.R. The estimated Net Worth of Ivan Tornos is at least $5.79 Million dollars as of 3 December 2021. Elizabeth Hofheinz, M.P.H., M.Ed. WARSAW Zimmer Biomet Holdings, Inc. recently announced that Ivan Tornos has been appointed to the newly created position of Chief Operating Officer. Cautionary Note Regarding Forward-Looking Statements. A search is underway for a new President of the EMEA region. Mr. Tornos joined Zimmer Biomet in November 2018 as Group CMS Creating Rule for Expedited Medicare Coverage, Cartilage Repair Rising, Reop Rates Falling: New UCSF Study, Taking Another, Deeper Look at Vertebral Body Tethering. 574-372-4250 In addition, he makes 4,196,910$ as Group President - Global Businesses and Americas at Zimmer Biomet Inc. Tornos joined the Warsaw, Indiana-based company in November 2018 as president of the orthopedics group, became group president of global business and the Americas in 2019 and was promoted to serve as chief operating officer a new position at Zimmer Biomet in March 2021. His responsibilities now extend beyond the Americas region, as he will now have oversight of the Europe, Middle East and Africa (EMEA) region, with the President of EMEA reporting directly to him., "Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board," said Hanson. Tornos has been serving as Group President, Global Businesses, and the Americas. We already have strong leaders in place for all key functions, and Im proud to work alongside them to further integrate activities, from global operations to clinical and medical education to global research and development and new product development., Also, Im excited to have more direct engagement with the EMEA team and to partner with the businesses as we work towards the pandemic recovery. About Ivan Tornos Axis Spine Raises $12.5M in Series A Financing Round, Arjun Ishwar Joins Miach Orthopaedics as VP Sales & Marketing, New Mesenchymal Stem Cell Company Launched, LRE System and Ortho Consulting Group Partnering, FDA Clears New Extremity Tendon Repair System, Patrick Seiler Is Spire Orthopedics New CFO, Using Amniotic Membrane Barrier in ALIF Surgery, A Giant Upon Whose Shoulders We Stand Has Died, This Spine Surgeon Wrote THE Book on Mental Health, Patrick Sweeney, M.D. Zimmer Biomet (NYSE:ZBH) announces that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. "Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board," said Mr. Hanson. Liked by Ivan Tornos Join now to see all activity Experience Zimmer Biomet 4 years 1 month CHIEF OPERATING OFFICER Mar 2021 - Present1 year 9 months United States Accountability for all. The ZBEdge Connected Intelligence Suite enables healthcare professionals to connect the dots between procedural and patient data at every stage of the surgical journey. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. ", Prior to his time at Zimmer Biomet, Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. Before that, Tornos held several positions with C.R. Ivan Tornos is Chief Operating Officer at Zimmer Biomet. "We wish Didier continued success in his next career endeavor," said Mr. Hanson. The result, which beat the 5.8 billion analyst consensus, was driven by growth in Siemens Healthineers' imaging unit, its largest business.Unit sales grew 17.3%, or 8.1% on a comparable basis, driven by demand for magnetic resonance imaging and . Together with healthcare professionals, we help millions of people live better lives. Save my name, email, and website in this browser for the next time I comment. "On behalf of the Zimmer Biomet team, I want to thank him for his strong and collaborative partnership over the last three years and for his commitment to ensuring a smooth and successful transition of his responsibilities.". In this new role, he will continue to report directly to Bryan Hanson, President and CEO, and will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading the global operations, clinical and medical education and global R&D and New Product Development functions. For more information, visit www.zimmerbiomet.com. Before joining C.R. Robotic Assist vs Free-Hand Screw Placement: Which Wins? Ivan Tornos is Chief Operating Officer at Zimmer Biomet Holdings Inc. See Ivan Tornos's compensation, career history, education, & memberships. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. In the new role, in addition to his continued leadership of the Americas region, he will now oversee Europe, Middle East, and Africa (EMEA) region. According to the press release Tornos, who will continue to report directly to Bryan Hanson, President and CEO, and will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading the global operations, clinical and medical education and global R&D and New Product Development functions. Ivan Tornos made $4,142,242 in total compensation as Group President, Global Businesses and Americas at Zimmer Biomet Holdings Inc in 2020.$1,381,602 was received as Total Cash, $2,650,078 was received as Equity and $110,562 was received as Pension and other forms of compensation. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. In addition, he makes $4,196,910 as Group President - Global Businesses and Americas at Zimmer Biomet Inc. The estimated Net Worth of Ivan Tornos is at least 5.88 $ dollars as of 3 December 2021. Joining me today are Bryan Hanson, our Chairman, President and CEO; EVP and CFO, Suky Upadhyay; and COO, Ivan Tornos. Mr. Tornos comes to Zimmer Biomet having served for more than two decades in various global roles for Fortune 50 to 500 companies. This cautionary note is applicable to all forward-looking statements contained in this news release. In this newly created position, Mr. Tornos will be responsible for increased innovation, implementation and execution of the Orthopedics group, which will include our large joint, sports, extremities and trauma (S.E.T.) Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating . Media Earlier, he was with C.R. Before joining C.R. This release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Ivan Tornos Chief Operating Officer Kenneth R. Tripp Senior Vice President, Global Operations and Logistics Suketu Upadhyay Executive Vice President and Chief Financial Officer Sang Yi President, Asia Pacific Lori Winkler Senior Vice President and Chief Human Resources Officer Wilfred van Zuilen President, Europe, Middle East and Africa warsaw, ind., october 31, 2018 - zimmer biomet holdings, inc. (nyse and six: zbh), a global leader in musculoskeletal healthcare, today announced ivan tornos, previously worldwide president for urology/medical and critical care at becton, dickinson and company (nyse: bdx), will join zimmer biomet as group president, orthopedics, effective In the near-term, Mr. Deltort will continue to oversee marketing, sales and distribution of products, services and solutions in the EMEA region, partnering closely with Mr. Tornos. Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Tue, April 13th, 2021 Ivan Tornos / Courtesy of Zimmer BiometHoldings, Inc. Ivan Tornos, group president of Global Businesses and the Americas at Warsaw, Indiana-based Zimmer Biomet, has been named as the company's Chief Operating Officer (COO)a newly-created position. 19, 2021, 07:00 AM WARSAW, Ind., March 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan. Bard in positions of increasing responsibility, most recently serving as President, Europe, Middle East and Africa Regions. 4mo. Please disable your ad-blocker and refresh. Forward-looking statements speak only as of the date made. Mr. Ivan Tornos is a Chief Operating Officer at Zimmer Biomet Holdings, Inc., a President at Biomet, Inc. and a President at Biomet Leasing, Inc. Mr. Tornos was previously employed as a President-Europe, Middle East & Africa Regions by C. R. Bard, Inc. Coleman Lannum Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. Tornos has been serving as Group. WARSAW,Ind., March 19, 2021 /PRNewswire/ --Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Privacy Policy, Winner of the MORE Award in Journalistic Excellence in Orthopedics. derek.davis@zimmerbiomet.com, California Transparency in Supply Chain Act Disclosure. We have operations in more than 25 countries around the world and sell products in more than 100 countries. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Ivan Tornos / Courtesy of Zimmer BiometHoldings, Inc. This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Ivans exceptional track record of executing on commercial strategies and driving growth and profitability will be critical to Zimmer Biomet as we continue our focus on achieving sustained performance in the business.. (WARSAW, IN) March 19, 2021Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the newly-created position of Chief Operating Officer. Ivan Tornos, group president of Global Businesses and the Americas at Warsaw, Indiana-based Zimmer Biomet, has been named as the companys Chief Operating Officer (COO)a newly-created position. WARSAW, Ind., October 31, 2018 - Zimmer Biomet Holdings, Inc. , a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide . Mr. Tornos is an alumnus of the Harvard Business School, having graduated from the Advanced Management Program and he also completed leadership and management programs at the Cox School of Business of Southern Methodist University. This site uses Akismet to reduce spam. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. | April 13, 2022 He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance), holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. Prior to joining Zimmer Biomet, Mr. Tornos served as Worldwide President of the Global Urology, Medical and Critical Care Division of Becton, Dickinson and Company. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Additionally, Im excited to accelerate innovation across our integrated portfolio of robotics and digital technologies as we work towards delivery of data-powered clinical insights that are shared seamlessly across the patient journey., Your email address will not be published. Cautionary Statement Regarding Forward-Looking Statements Q4 insights: Siemens Healthineers, a market leader in diagnostic imaging, has posted quarterly revenue of 6 billion for the first time. 321,958 followers. Mar. (RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) Friday announced the appointment of Ivan Tornos as Chief Operating Officer, a newly created position. He also served as International Vice President, Business Development and Strategy with Baxter International Inc., and prior to that he spent over a decade in leadership assignments around the globe with Johnson & Johnson. Ivan Tornos Chief Operating Officer Ivan Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics, and a year later was named Group President, Global Businesses and the Americas. Arjun Ishwar joins Miach Orthopaedics, Inc. as vice president of sales and marketing. Ivan Tornos' Post. Sues DePuy Synthes for Patent Infringement. LRE Systems restorative elbow joint system brought to global market via a strategic partnership with OCG. 574-371-9480 ZBEdge technologies are designed with the dual goals of reducing variability of care and enhancing outcomes," said Ivan Tornos, Chief Operating Officer at Zimmer Biomet. WARSAW, Ind., October 31, 2018 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company (NYSE: BDX), will join Zimmer Biomet as Group President, Orthopedics, effective November 1, 2018. Copyright 2022 RRY Publications, LLC. Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Monica Kendrick . Axis Spine, a spinal implant manufacturer, has closed a successful $12.5 million Series A financing round. On this week's episode of DeviceTalks, our Chief Operating Officer Ivan Tornos shares the latest updates to our innovative portfolio and dives into how we . Bard involved serving as Vice President and General Manager of the Americas Pharmaceutical and Medical/Imaging segments of Covidien International. In addition to his continued leadership of the Americas region, Mr. Tornos will now have oversight of the Europe, Middle East and Africa (EMEA) region, with the President of EMEA reporting directly to him. We collaborate with healthcare professionals around the globe to advance the pace of innovation. Readers of this news release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. Is this happening to you frequently? Mr. Tornos has joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. zimmer biomet holdings inc. announced it has appointed ivan tornos as chief operating officer, a newly created position in the company, according to a company press release.the release noted. Recommandations des analystes sur ZIMMER BIOMET HOLDINGS: 03/11: Zimmer Biomet Holdings : Citigroup maintient sa recommandation ne.. ZM. Go to DeviceTalks.com to hear the entire conversation. Earlier, he was with C.R. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. As a Spaniard, I have a true passion for my home continent and I am looking forward to being more directly engaged with the EMEA team., As COO, I will continue the strong momentum weve started with the Global Businesses and the Americas teams. | March 27, 2022 For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with theU.S.Securities and Exchange Commission (SEC). Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas. Learn how your comment data is processed. Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later wasnamedGroup President, Global Businesses and the Americas. WARSAW, Ind., October 31, 2018 - Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company (NYSE: BDX), will join Zimmer Biomet as Group President, Orthopedics, effective November 1, 2018. Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post Tornos Continues to Lead Global Businesses and Americas; Will Now Also Oversee Europe,. He finalized post-MBA work at the Wharton School of the University of Pennsylvania, holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business., We asked Mr. Tornos what he anticipates will be the most exciting aspect of this expanded role: In this newly-created role, I will continue to drive our global business forward and will take further steps to integrate all aspects as we innovate and execute on our mission to alleviate pain and improve the quality of life for people around the world. Welcome to Zimmer Biomet's third quarter 2022 earnings conference call. WARSAW, Ind., March 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. , a global leader in musculoskeletal healthcare, today announced that Ivan Tornos has been appointed to the. We have operations in more than 25 countries around the world and sell products in more than 100 countries. Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. . Mr. Tornos owns over 3,538 units of Zimmer Biomet Inc stock worth over $1,589,121 and over the last 4 years he sold ZBH stock worth over $0. Zimmer Biomet Holdings, Inc. announced Ivan Tornos, previously Worldwide President for Urology/Medical and Critical Care at Becton, Dickinson and Company, will join Zimmer Biomet as Group President,. He also held the position of International Vice President, Business Development and Strategy with Baxter International Inc., and before that Tornos spent over a decade in international leadership with Johnson & Johnson., Ivan Tornos graduated from Harvard Business School and completed leadership and management programs at the Cox School of Business of Southern Methodist University.
Pure Bliss Almond Pumpkin, Ayurvedic Treatment For Female Pattern Baldness, Ranch Homes With Basement Near Zagreb, Passive Speaking Activities, What Method Of Assessment Do Waldorf Teachers Use?, El Rio Recreation Center, Darpan Admission Portal 2022, Military Travel Restrictions Update, Flipped Book Age Rating, Lithuania Ukraine News,